World Alzheimer’s Day 2022

An estimated 50 million people around the world currently live with Alzheimer's disease or other dementias, dementia being a collective term for progressive syndromes that affect various expressions of cognitive function, such as memory and emotional expression. Alzheimer’s disease accounts for the majority of cases (50 to 70%, varying by country, based on Alzheimer’s Disease International and World Health Organization figures). For those directly affected and their loved ones, dementia can be a frightening experience, particularly as it is so poorly understood. However there remains little or no understanding of dementia in many, and the stigmatization and misinformation that surrounds dementia remains a global issue.

For 2022 World Alzheimer’s Day the theme Know Dementia, Know Alzheimer’s, organized annually by Alzheimer’s Disease International, focuses on diagnosis, the warning signs of dementia, with a special focus on post-diagnosis support. The aim of this international campaign is to highlight the importance of support for people living with dementia and families following a diagnosis.


European Journal of Vascular and Endovascular Surgery, Volume 63, April 2022

This article explores whether operations for carotid artery diseases reduce the risk of dementia.
Cross-sectional and longitudinal soluble TREM2 levels in CSF according to estimated years to symptom onset (EYO) in carriers and non-carriers of pathogenic variants.

The Lancet Neurology, Volume 21, April 2022

An article on Alzheimer's disease progression, in the context of SDG 3, focusing specifically on the dynamics of soluble TREM2 and its association with amyloid and tau markers, neuroimaging features, and cognition.

The Lancet Regional Health - Europe, Volume 15, April 2022

An article on dementia risk, in the context of SDGs 3 and 10, focusing specifically on the association between ethnicity, socioeconomic deprivation, and dementia risk.

Frontiers in Neuroendocrinology, Volume 65, April 2022

In vitro and in vivo studies showed that melatonin therapy is effective against AD. The emerging novel melatonin-based therapies are potential treatment options in AD.

eClinicalMedicine, Volume 45, March 2022

An article on global spending of dementia care, in the context of SDG 3, focusing specifically on modelling global and regional estimates from 2000 to 2019 and expected future scenarios from 2020 to 2050.

The Lancet Planetary Health, Volume 6, March 2022

An article on air pollution and cognitive decline, in the context of SDGs 3 and 11, focusing specifically on the association between exposure to outdoor air pollutants and cognitive performance.

The Lancet Healthy Longevity, Volume 3, March 2022

An article on comorbid dementia and depression, in the context of SDG 3, focusing specifically on the effectiveness of music interventions on depressive symptoms for people with dementia.
Change in incidence rate over time in the Alzheimer's disease cohort for health conditions significantly associated with the disease.

The Lancet Digital Health, Volume 4, March 2022

An article on Alzheimer's disease risk, in the context of SDG 3, focusing specifically on the association between health conditions diagnosed in primary care and incident Alzheimer's disease.

Journal of Aging Studies, Volume 60, March 2022

This article addresses ways to share the burden of care for those with dementia.

American Journal of Obstetrics and Gynecology, Volume 226, March 2022

Mental health condition diagnoses were associated with other underlying chronic health conditions and a modestly increased risk of a range of adverse outcomes. The findings suggested that mental health conditions are an important risk factor in adverse maternal outcomes.